A Long Term Extension Study to Evaluate the Safety and Efficacy of Afimkibart (RO7790121) in Participants With Atopic Dermatitis

Hamilton Research, LLC, Alpharetta, Georgia, United States

Revival Research Institute, LLC, Troy, Michigan, United States

Best Skin Research LLC, Camp Hill, Pennsylvania, United States

Centro de Estudos em Terapias Inovadoras ? CETI, Curitiba, Paraná, Brazil

Irmandade Da Santa Casa de Misericordia de Porto Alegre, Porto Alegre, Rio Grande do Sul, Brazil

Hospital de Clnicas de Porto Alegre, Porto Alegre, Rio Grande do Sul, Brazil

UNESP - Faculdade de Medicina da Universidade Estadual Paulista - Campus Botucatu, Botucatu, São Paulo, Brazil

Centro de Pesquisa São Lucas, Campinas, São Paulo, Brazil

HMCG - Hospital e Maternidade Dr. Christovo da Gama, Santo Andr, São Paulo, Brazil

Fundacao Faculdade Regional de Medicina de Sao Jose Do Rio Preto Hospital de Base - PPDS, Sao Jose Rio Preto, São Paulo, Brazil

Instituto Brasil de Pesquisa Clínica-IBPCLIN S/A, Rio de Janeiro, Brazil

DermEffects, London, Ontario, Canada

Lynderm Research Inc, Markham, Ontario, Canada

DermEdge, Mississauga, Ontario, Canada

Ryan Clinical Research Inc, Newmarket, Ontario, Canada

Fachklinik Bad Bentheim, Bad Bentheim, Lower Saxony, Germany

Dermatologikum Hamburg Gemeinschaftspraxis GbR, Hamburg, Germany

Centrum Medyczne Pratia Katowice I, Katowice, Silesian Voivodeship, Poland

Centrum Medyczne Pratia Gdynia, Gdynia, Poland

Specjalistyczny Gabinet Dermatologiczny dr n. med. Pawel Brzewski, Krakow, Poland

Centrum Nowoczesnych Terapii "Dobry Lekarz", Krakow, Poland

Uniwersytecki Szpital Kliniczny im.Fryderyka Chopina w Rzeszowie, Rzeszów, Poland

Klinika Ambroziak Dermatologia, Warsaw, Poland

Hospital Universitario Reina Sofia, Córdoba, Spain